Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2008-12-17
2010-02-23
Graser, Jennifer E (Department: 1645)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C536S023100, C536S023700, C536S024100, C435S320100, C435S071100, C435S243000, C435S252300
Reexamination Certificate
active
07666626
ABSTRACT:
A P4 variant protein that has reduced enzymatic activity and that induces antibody to wild-type P4 protein and/or has good bactericidal activity against non-typableH. influenzae(NTHi) is useful as an active component in an immunogenic composition for humans. Methods of using these proteins, and compositions containing them in combination with additional antigens, are also provided.
REFERENCES:
patent: 4518526 (1985-05-01), Olson
patent: 4542104 (1985-09-01), Stryer et al.
patent: 4554101 (1985-11-01), Hopp
patent: 4599197 (1986-07-01), Wetzel
patent: 4734362 (1988-03-01), Hung et al.
patent: 4777127 (1988-10-01), Suni et al.
patent: 4912094 (1990-03-01), Myers et al.
patent: 5057540 (1991-10-01), Kensil et al.
patent: 5078996 (1992-01-01), Conlon, III et al.
patent: 5091309 (1992-02-01), Schlesinger et al.
patent: 5185440 (1993-02-01), Davis et al.
patent: 5217879 (1993-06-01), Huang et al.
patent: 5219740 (1993-06-01), Miller et al.
patent: 5272257 (1993-12-01), Gupta
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5593972 (1997-01-01), Weiner et al.
patent: 5601831 (1997-02-01), Green et al.
patent: 5698202 (1997-12-01), Ertl et al.
patent: 5703055 (1997-12-01), Felgner et al.
patent: 5723127 (1998-03-01), Scott et al.
patent: 5739118 (1998-04-01), Carrano et al.
patent: 5780601 (1998-07-01), Green et al.
patent: 5837533 (1998-11-01), Boutin
patent: 5955580 (1999-09-01), Green et al.
patent: 6083716 (2000-07-01), Wilson et al.
patent: 6113918 (2000-09-01), Johnson et al.
patent: 6127170 (2000-10-01), Boutin
patent: 6168918 (2001-01-01), Satishchandran et al.
patent: 6207646 (2001-03-01), Krieg et al.
patent: 0345242 (1989-12-01), None
patent: 0415731 (1991-03-01), None
patent: 0462210 (1991-12-01), None
patent: 0606921 (1994-07-01), None
patent: 2200651 (1988-08-01), None
patent: WO-90/07936 (1990-07-01), None
patent: WO-91/02805 (1991-03-01), None
patent: WO-90/10458 (1991-12-01), None
patent: WO-92/10578 (1992-06-01), None
patent: WO-92/19265 (1992-11-01), None
patent: WO-93/03769 (1993-03-01), None
patent: WO-93/09239 (1993-05-01), None
patent: WO-93/10218 (1993-05-01), None
patent: WO-93/11230 (1993-06-01), None
patent: WO-93/13202 (1993-07-01), None
patent: WO-93/19191 (1993-09-01), None
patent: WO-93/25234 (1993-12-01), None
patent: WO-93/25698 (1993-12-01), None
patent: WO-94/03622 (1994-02-01), None
patent: WO-94/12649 (1994-06-01), None
patent: WO-94/16737 (1994-08-01), None
patent: WO-94/21792 (1994-09-01), None
patent: WO-94/28938 (1994-12-01), None
patent: WO-95/00655 (1995-01-01), None
patent: WO-95/07994 (1995-03-01), None
patent: WO-95/11984 (1995-05-01), None
patent: WO-95/27044 (1995-10-01), None
patent: WO-95/27069 (1995-10-01), None
patent: WO-96/10038 (1996-04-01), None
patent: WO-99/21591 (1999-05-01), None
patent: WO-99/45966 (1999-09-01), None
patent: WO-00/18434 (2000-04-01), None
patent: WO-00/28061 (2000-05-01), None
patent: WO-00/55335 (2000-09-01), None
patent: WO-01/83692 (2001-11-01), None
Verma et al, (Nature, vol. 389, No. 6648, pp. 239-242, 1997).
Rochlitz C. F. (Swiss Medicine Weekly,131:4-9, 2001).
Vile et al (Gene Therapy, vol. 7, pp. 2-8, 2000).
Greenspan et al (Nature Biotechnology 7: 936-937, 1999).
Chothia et al (The EMBO Journal, 1986, 5/4:823-26).
Alvarado-Urbina, et al., “Automated synthesis of gene fragments”, Science, vol. 214, (Oct. 16, 1981)pp. 270-274.
Amann, et al., “Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins inEscherichia coli”, Gene, vol. 69, No. 2, (Sep. 30, 1988)pp. 301-315.
Andersen, et al., “Herpesvirus-mediated gene delivery into the rat brain: specificity and efficiency of the neuron-specific enolase promoter”, Cellular Molecular Neurobiology, vol. 13, No. 5, (Oct. 1993)pp. 503-515.
Arbuthnot, et al., “In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector”, Human Gene Therapy, vol. 7, No. 13, (Aug. 20, 1996)pp. 1503-1514.
Barba, et al., “Thymidine kinase-mediated killing of rat brain tumors”, Journal of Neurosurgery, vol. 79, No. 5, (Nov. 1993)pp. 729-735.
Berkner, K.L., “Development of adenovirus vectors for the expression of heterologous genes”, Biotechnology, vol. 6, No. 7, (Jul. (Aug.)-1988)pp. 616-629.
Boshart, et al., “A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus”, Cell, vol. 41, No. 2, (Jun. 1985)pp. 521-530.
Caillaud, et al., “Adenoviral vector as a gene delivery system into cultured rat neuronal and glial cells”, European Journal of Neuroscience, vol. 5, No. 10, (Oct. 1, 1993)pp. 1287-1291.
Chen, et al., “Expression of rat bone sialoprotein promoter in transgenic mice”, Journal of Bone Miner Res., vol. 11, No. 5, (May 1996)pp. 654-664.
Collins, et al., “Molecular sequence comparison and alignment” in Practical Approach Series: Nucleic Acid and Protein Sequence Analysis XVIII, (M.J. Bishop et al., eds.) IRL Press: Oxford, England, UK (1987) pp. 417.
Collins, et al., “The significance of protein sequence similarities”, Computer Applications in Bioscience, vol. 4, No. 1, (Mar. 1988)pp. 67-71.
Deich, et al., “Cloning of genes encoding a 15,000-dalton peptidoglycan-associated outer membrane lipoprotein and an antigenically related 15,000-dalton protein fromHaemophilus influenzae”, Journal of Bacteriology, vol. 170, No. 2, (Feb. 1988)pp. 489-498.
Fleischmann, et al., “Whole-genome random sequencing and assembly ofHaemophilus influenzaeRd”, Science, vol. 269, No. 5223, (Jul. 28, 1995)pp. 496-512.
Flotte, et al., “Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector”, Proceedings of the National Acedemy of Science USA, vol. 90, No. 22, (Nov. 15, 1993)pp. 10613-10617.
Gase, et al., “The lppC gene ofStreptococcus equisimilisencodes a lipoprotein that is homologous to the e (P4) outer membrane protein fromHaemophilus influenzae”, Medical Microbiology and Immunology, vol. 186, No. 1, (Jun. 1997)pp. 63-73.
Gething, et al., “Cell-surface expression of influenza haemagglutinin from a cloned DNA copy of the RNA gene”, Nature, vol. 293, No. 5834, (Oct. 22, 1981)pp. 620-625.
Gossen, et al., “Tight control of gene expression in mammalian cells by tetracycline-responsive promoters”, Proceedings of the National Academy of Science USA, vol. 89, No. 12, (Jun. 15, 1992)pp. 5547-5551.
Gossen, et al., “Transcriptional activation by tetracyclines in mammalian cells”, Science, vol. 268, No. 218, (Jun. 23, 1995)pp. 1766-1769.
Green, et al., “Certain site-directed, nonenzymatically active mutants of theHaemophilus influenzaP4 lipoprotein are able to elicit bactericidal antibodies,” Infection & Immunity, vol. 73, No. 7, (Jul. 2005)pp. 4454-4457.
Green, et al., “A recombinant non-fatty acylated form of the Hi-PAL (P6) protein ofHaemophilus influenzaeelicits biologically active antibody against both nontypeable and type b H. influenzae”, Infection & Immunity, vol. 58, No. 10, (Oct. 1990)pp. 72-3278.
Green, et al., “The e(P4) outer membrane protein ofHaemophilus influenzae: Biologic activity of anti-e serum and cloning and sequencing of the structural gene”, Infection & Immunity, vol. 59, No. 9, (Sep. 1991)pp. 3191-3198.
Guzman, et al., “Efficient and selective adenovirus-mediated gene transfer into vascular neointima”, Circulation, vol. 88, No. 6, (Dec. 1993)pp. 2838-2848.
Guzman, et al., “Efficient gene transfer into myocardium by direct injection of adenovirus vectors”, Circulation, vol. 73, No. 6, (Dec. 1993)pp. 1202-1207.
Guzman, et al., “Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter”, Journal of Bacteriology, vol. 177, No. 14, (Jul. 1995)pp. 121-4130.
Hansal, et al., “Induction of antigen-specific hypores
Fletcher Leah D.
Green Bruce A.
Reilly Thomas J.
Smith Arnold L.
Zlotnick Gary W.
Gordon, Esq. Alan M.
Graser Jennifer E
Howson & Howson LLP
The Curators of the University of Missouri
Wyeth Holdings Corporation
LandOfFree
Mutants of the P4 protein of nontypable Haemophilus... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutants of the P4 protein of nontypable Haemophilus..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutants of the P4 protein of nontypable Haemophilus... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4183975